Cost-Effectiveness of an Intensive Upper Limb Rehabilitation Therapy for Children With Unilateral Cerebral Palsy: An

Michael C David1,2, Hideki Higashi3

  • 1School of Medicine and Dentistry, Griffith University, Gold Coast, Australia.

Insights

Intensive therapy for unilateral cerebral palsy improved quality of life but was not consistently cost-effective. Only the pain and disability domain showed a high probability of being cost-effective over 13 weeks.

Area of Science:

  • Pediatric Rehabilitation
  • Health Economics
  • Childhood Disability Studies

Background:

  • Unilateral cerebral palsy (UCP) significantly impacts childhood disability and incurs substantial economic costs.
  • Intensive group-based therapy, combining constraint-induced movement and bimanual therapies, shows promise for improving UCP-related quality of life.
  • Assessing the cost-effectiveness of this intensive intervention against standard care is crucial for resource allocation.

Purpose of the Study:

  • To evaluate the cost-effectiveness of an intensive, hybrid therapy intervention for children with unilateral cerebral palsy compared to standard care.
  • To analyze the impact of the intervention on various quality-of-life domains as measured by the Cerebral Palsy Quality of Life (Child) questionnaire.

Main Methods:

  • An open-label, parallel randomized controlled trial with an embedded economic evaluation.
  • 47 children with UCP were randomized into an intervention group (n=27) or a standard care group (n=20).
  • Nonparametric bootstrapping was utilized to determine uncertainty intervals for incremental cost-effectiveness ratios.

Main Results:

  • The intervention demonstrated incremental cost-effectiveness ratios ranging from $107 to $1071 for the Family Health domain.
  • For the Pain and Impact of Disability domain, the intervention showed a probability exceeding 0.75 of being cost-effective.
  • Cost-effectiveness was not sufficiently demonstrated for other domains within the 13-week study period.

Conclusions:

  • The intensive hybrid therapy intervention for unilateral cerebral palsy shows potential cost-effectiveness specifically for the Pain and Impact of Disability domain.
  • Insufficient evidence exists to support the cost-effectiveness of this intervention over standard care for other quality-of-life domains within a 13-week timeframe.
  • Further research may be needed to explore long-term cost-effectiveness and broader applicability of the intervention.

Related Concept Videos